TCW Special Purpose Acquisition Corp.
Status: Liquidated
U=S+W/3
W=S@11.5
IPO Proceeds, $M | $463.93M |
---|---|
IPO Date | Mar 2, 2021 |
CEO | Joseph R. Shaposhnik |
Left Lead | Citigroup |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24+(3) |
IPO Sector |
General
Technology, healthcare, industrial or consumer |
IPO Geography | Global |
Target Company | N/A |
Deal Announced | N/A |
Deal Size, $M | TBD |
Deal Sector | TBD |
Deal Geography | TBD |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | Dec 15, 2022 |
Closing Date | Dec 15, 2022 |
TSPQ
TSPQ.U
TSPQ/W
Price | |
---|---|
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on TCW Special Purpose Acquisition Corp.:
- Structure and cap table
- 11 directors & officers
- 15 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Joseph R. Shaposhnik | 37 | Chairman and CEO |
Richard Villa | 58 | CFO and Secretary |
Meredith Jackson | 61 | Director |
Carol P. Lowe | 55 | Director |
Leo L. Chan | 38 | Director |
Nanxi Liu | Director | |
Brian Lee | Director | |
David Rye | Director | |
Brad Buss | Advisor | |
Thomas Tippl | Advisor | |
Simon Gallagher | Advisor |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Filings
Sign in to view 15 filings.